Speaker illustration

Doctor Feriel Azibani

University of Cape Town, Rondebosch (South Africa)

Different outcome and fibrosis marker profiles suggest different pathomechanisms for peripartum cardiomyopathy in German and South African patients

Event: Heart Failure 2018

Topic: Pathophysiology and Mechanisms

Session: Acute Heart Failure – Pathophysiology and Mechanisms

Thumbnail

Targeted interventions reducing late maternal death due to heart failure

Event: Heart Failure 2018

Topic: Treatment

Session: Acute Heart Failure– Treatment

Thumbnail

Circulating growth-differentiation factor 15 in peripartum cardiomyopathy

Event: ESC Congress 2016

Topic: Pathophysiology and diagnosis

Session: Heart failure/Left ventricular function

Thumbnail

Galectin 3 plasma levels at baseline correlate with poor clinical outcome in patients with peripartum cardiomyopathy

Event: HEART FAILURE 2016

Topic: Prognosis (using biomarkers)

Session: Basic Science: Biomarkers

Thumbnail